Implantation of Cardiac Electronic Devices in Active COVID-19 Patients. Results from an International Survey

Cardiac Arrest or Death

Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry

Eur J Heart Fail.

Cikes M, Jakus N, Claggett B, Brugts JJ, Timmermans P, Pouleur AC, Rubis P, Van Craenenbroeck EM, Gaizauskas E, Grundmann S, Paolillo S, Barge-Caballero E, D'Amario D, Gkouziouta A, Planinc I, Veenis JF, Jacquet LM, Houard L, Holcman K, Gigase A, Rega F, Rucinskas K, Adamopoulos S, Agostoni P, Biocina B, Gasparovic H, Lund LH, Flammer AJ, Metra M, Milicic D, Ruschitzka F, PCHF-VAD registry.

doi: 10.1002/ejhf.1568.

Further Publications

European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID), and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

Eur Heart J.

Blomström-Lundqvist C, Traykov V, Erba PA, Burri H, Nielsen JC, Bongiorni MG, Poole J, Boriani G, Costa R, Deharo JC, Epstein LM, Sághy L, Snygg-Martin U, Starck C, Tascini C, Strathmore N

doi: 10.1093/eurheartj/ehaa010.

Cardiovascular Risk and Diseases

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

JAMA Cardiol.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, Gong W, Liu X, Liang J, Zhao Q, Huang H, Yang B, Huang C

doi: 10.1001/jamacardio.2020.0950.

Cardiac Arrest or Death

In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China

Resuscitation.

Shao F, Xu S, Ma X, Xu Z, Lyu J, Ng M, Cui H, Yu C, Zhang Q, Sun P, Tang Z

doi: 10.1016/j.resuscitation.

Cardiovascular Risk and Diseases

Cardiac complications in patients hospitalised with COVID-19

Eur Heart J Acute Cardiovasc Care

Linschoten M, Peters S, van Smeden M, Jewbali LS, Schaap J, Siebelink HM, Smits PC, Tieleman RG, van der Harst P, van Gilst WH, Asselbergs FW, CAPACITY-COVID collaborative consortium.

doi: 10.1177/2048872620974605

Further Publications

Renin-Angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry

Am Heart J

Núñez-Gil IJ, Olier I, Feltes G, Viana-Llamas MC, Maroun-Eid C, Romero R, Fernández-Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, García-Aguado M, Elola J, Castro-Mejía A, Pepe M, Garcia-Prieto JF, Gonzalez A, Ugo F, Cerrato E, Bondia E, Raposeiras S, Mendez JLJ, Espejo C, Masjuan ÁL, Marin F, López-Pais J, Abumayyaleh M, Corbi-Pascual M, Liebetrau C, Ramakrisna H, Estrada V, Macaya C, HOPE COVID-19 investigators (Cols appendix).

doi: 10.1016/j.ahj.2021.04.001

Cardiovascular Risk and Diseases

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy

Eur Heart J.

Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, Curnis A, Faggiano P, Gorga E, Lombardi CM, Milesi G, Vizzardi E, Volpini M, Nodari S, Specchia C, Maroldi R, Bezzi M, Metra M

doi: 10.1093/eurheartj/ehaa388.

Further Publications

Antibacterial Envelope to Prevent Cardiac Implantable Device Infection

N Engl J Med.

Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, Gallastegui J, Pickett RA, Evonich R, Philippon F, McComb JM, Roark SF, Sorrentino D, Sholevar D, Cronin E, Berman B, Riggio D, Biffi M, Khan H, Silver MT, Collier J, Eldadah Z, Wright DJ, Lande JD, Lexcen DR, Cheng A, Wilkoff BL; WRAP-IT Investigators

doi: 10.1056/NEJMoa1901111.

Therapy and Intervention

Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial

Europace.

Steffel J, Ruff CT, Braunwald E, Hamershock RA, Murphy SA, Nieminen M, Lanz HJ, Mercuri MF, Peterson N, Antman EM, Giugliano RP

doi: 10.1093/europace/euy253.

Related content

Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry

Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China

In-hospital cardiac arrest outcomes among patients with COVID-19 pneumonia in Wuhan, China

Cardiac complications in patients hospitalised with COVID-19

Renin-Angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry

Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy

Antibacterial Envelope to Prevent Cardiac Implantable Device Infection

Edoxaban and implantable cardiac device interventions: insights from the ENGAGE AF-TIMI 48 trial